Goodman Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-114
Closed -$11K 200
2025
Q4
$11K Buy
+114
New +$11.1K ﹤0.01% 140
2023
Q2
Sell
-15,321
Closed -$1.24M 173
2023
Q1
$1.24M Buy
15,321
+236
+2% +$19.2K 0.67% 27
2022
Q4
$1.17M Buy
15,085
+6,455
+75% +$523K 0.68% 30
2022
Q3
$697K Sell
8,630
-15,626
-64% -$1.4M 0.38% 31
2022
Q2
$2.18M Buy
+24,256
New +$2.46M 0.97% 21

Other funds holding MDT

Goodman Advisory Group's MDT Position: Q1 2026 in Review

Goodman Advisory Group sold out of Medtronic (MDT) in Q1 2026, closing a stake of 114 shares — an estimated $11K sold.

Goodman Advisory Group first reported a position in MDT in Q2 2022 and held it in 5 quarters. The position peaked at $2.18M in Q2 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Goodman Advisory Group reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Goodman Advisory Group sold 114 Medtronic shares in Q1 2026, an estimated $11K.
  • Goodman Advisory Group first reported a position in Medtronic in Q2 2022 and held it in 5 quarters.
  • Goodman Advisory Group's Medtronic position peaked at $2.18M in Q2 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.